Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. Its Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, solutions, and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services, and digital solutions and applications for managing treatment and therapy. Its Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms. It offers essential technical customer service, such as maintenance and repair; medical equipment performance management; training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as digital healthhcare consulting, products, and services. The company was incorporated in 2017 and is headquartered in Forchheim, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.

Siemens Healthineers AG

Dr. Bernhard  Montag Ph.D.

President, CEO & Chairman of Management Board

Dr. Jochen  Schmitz Ph.D.

CFO & Member of Management Board

Ms. Darleen  Caron

Chief Human Resources Officer, Labor Director & Member of Management Board

Ms. Elisabeth  Staudinger-Leibrecht M.A.

Member of Management Board

Mr. Marc  Koebernick

Head of Investor Relations

Christian  Klaussner

Executive Vice President of Finance

Andre  Hartung

Head of Imaging

Carsten  Bertram

Head of Advanced Therapies

Mr. David C. Pacitti M.B.A.

Head of Americas

Ms. Sharon J. Bracken

Head of Diagnostics

SHL's next earnings is on February 6, 2025 (After Market Close)

SHL's latest dividend is 0.95 EUR on April 19, 2024

Siemens Healthineers AG (SHL) Stock Analysis, Discussion Forum and Financial Metrics - XETRA Exchange

Siemens Healthineers AG (SHL) Earnings Report Date and History | XETRA

SHL's next earnings is on February 6, 2025 (After Market Close)

When is the earnings report for SHL?

SHL Earnings History

SHL's latest dividend is 0.95 EUR on April 19, 2024

SHL Stock Discussion Forum and Message Board

News for XETRA: SHL